Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells
Open Access
- 1 June 2000
- journal article
- Published by Elsevier
- Vol. 275 (25) , 19297-19305
- https://doi.org/10.1074/jbc.m905866199
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The GDNF Protein FamilyGene Ablation Studies Reveal What They Really Do and HowNeuron, 1999
- Ret in human development and oncogenesisBioEssays, 1997
- Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutationProceedings of the National Academy of Sciences, 1997
- Mechanism of Activation of the ret Proto-oncogene by Multiple Endocrine Neoplasia 2A MutationsMolecular and Cellular Biology, 1995
- Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2BScience, 1995
- Inherited cancers associated with the RET proto-oncogeneCurrent Opinion in Genetics & Development, 1994
- Receptor tyrosine kinases and their targetsCurrent Opinion in Genetics & Development, 1994
- Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung diseaseJournal of Cell Science, 1994
- A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions.Molecular and Cellular Biology, 1993
- Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21Nature, 1986